Evidence map›Paper›PMID 33231809›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.

Samantha J Mayo, Maryam Lustberg, Haryana M Dhillon, Zev M Nakamura, Deborah H Allen, Diane Von Ah, Michelle C Janelsins, Alexandre Chan, Karin Olson, Chia Jie Tan and 14 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. The effect of exercise on cognitive function in breast cancer survivors: systematic review and meta-analysis of randomized controlled trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  3. Cancer-related cognitive impairment in patients with hematologic malignancies after CAR T cell therapy: a systematic review and meta-analysis of prevalence.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  4. The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviews.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Associations between MoCA screening-positive cognitive impairment, anxiety, depression, and quality of life in patients with oral cancer: a cross-sectional study in China.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  16. Methodology of analysis of cognitive impairment in longitudinal randomized clinical trials in oncology: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  17. Accounting for unmet needs resulting from cancer-related cognitive impairment.Journal of cancer survivorship : research and practice · 2026
    Article
  18. Article
  19. Observational
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Samantha J MayoLawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada. samantha.mayo@utoronto.ca.ORCID http://orcid.org/0000-0002-0083-5679
Maryam LustbergThe Ohio State Comprehensive Cancer Center, Columbus, OH, USA.
Haryana M DhillonUniversity of Sydney, Sydney, Australia.
Zev M NakamuraUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Deborah H AllenDuke University Health System, Durham, NC, USA.
Diane Von AhIndiana University School of Nursing, Indianapolis, IN, USA.
Michelle C JanelsinsDepartment of Surgery, University of Rochester Medical Center, Rochester, NY, USA.
Alexandre ChanUniversity of California, Irvine, CA, USA.
Karin OlsonFaculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.
Chia Jie TanThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yi Long TohThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jeong OhPeter MacCallum Cancer Centre, Parkville, Australia.
Lisa GrechNational University of Singapore, Singapore, Singapore.
Yin Ting CheungSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
Ishwaria Mohan SubbiahPeter MacCallum Cancer Centre, Parkville, Australia.
Duska PetranovicClinical Hospital Center Rijeka, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
James D'OlimpioMonter Cancer Center, Northwell Cancer Institute, Lake Success, NY, USA.
Margherita GobboDivision of Oral Medicine and Pathology, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Susanne KoeppenLVR-Klinikum Essen, University of Duisburg-Essen, Essen, Germany.
Charles L LoprinziMayo Clinic Rochester, Rochester, MN, USA.
Linda PangKelsey-Seybold Clinic, Houston, TX, USA.
Shivani ShindeIntermountain Health, Murray, UT, USA.
Olanipekun NtukidemSt. Jude Children's Research Hospital, Memphis, TN, USA.
Katherine B PetersThe Preston Robert Tisch Brain Tumor Center, Duke University, Durham, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer-related cognitive impairment (CRCI) is commonly experienced by individuals with non-central nervous system cancers throughout the disease and treatment trajectory. CRCI can have a substantial impact on the functional ability and quality of life of patients and their families. To mitigate the impact, oncology providers must know how to identify, assess, and educate patients and caregivers. The objective of this review is to provide oncology clinicians with an overview of CRCI in the context of adults with non-central nervous system cancers, with a particular focus on current approaches in its identification, assessment, and management.

Indexed as

Cognitive DysfunctionHumansNeoplasmsCancerCancer-related cognitive impairmentChemotherapy-related cognitive impairmentCognitionCognitive functioningCRCI

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.